It's #Newstodon Friday!
Where my newsrooms at?!
@damemagazine @TexasObserver @TPR @azpm @thexylom @TheConversationUS @wausaupilot @STAT
show us that good #journalism stuff!!!
(see a newsroom? not a bot account? tag 'em in a reply so we can find 'em)
That's not what the ruling does, though.
To point out that the FDA broke the law in its processes surrounding the approval of this drug doesn't block access to the medication.
We SHOULD BE calling on the president to fix compliance with the law and Congress to reevaluate the law and probably reform it, but the distraction of focusing squarely on the court doesn't get us anywhere.
There are laws that I believe are too restrictive on medications, including this one. It's not the court's problem that they're having to work with bad laws.
@gbhnews @sarahutch @damemagazine @TPR @azpm @thexylom @TheConversationUS @wausaupilot @STAT
Go directly to the ruling and you'll see that plenty of press outfits are misreporting what's actually going on.
Here's a link to it:
@gbhnews @sarahutch @damemagazine @TPR @azpm @thexylom @TheConversationUS @wausaupilot @STAT
@volkris @gbhnews @sarahutch @damemagazine @TPR @azpm @thexylom @TheConversationUS @wausaupilot @STAT
"On April 7, U.S. District Judge Matthew Kacsmaryk of Amarillo, a Trump appointee, issued an unprecedented ruling pulling the Food and Drug Administration’s approval of the popular and safe abortion pill, mifepristone, effectively removing it from the U.S. market."
Meanwhile, real people are suffering as outlined in our article.